Search Results 901-910 of 39006 for Two-phase

  1. A Study To Assess The Effectiveness And Safety Of Pacritinib In Patients With VEXAS Syndrome (PAXIS) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. Renal Cell Carcinoma Clinical Trials - Mayo Clinic Research

    Mayo Clinic will be participating in both Part A (Phase 1) & (Phase 2) B of the study. ... The study consists of two stages: in the Dose Escalation Stage ...

  3. Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation - Mayo Clinic

    Phase 2 Study Of ALXN2030 In Patients With Antibody-Mediated Rejection After Kidney Transplantation · Overview · Participation eligibility · Participating Mayo ...

  4. Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  5. Musculoskeletal Gene Therapy Research Laboratory - Research projects

    A phase 1 study evaluating the safety of intra-articular sc-rAAV2. ... 2 (BMP-2) promotes bone healing. This study also ... During the course of these experiments, ...

  6. S1211, Bortezomib, Dexamethasone, and Lenalidomide With or Without Elotuzumab in Treating Patients With Newly Diagnosed High-Risk Multiple Myeloma - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  7. Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer - Mayo Clinic

    ... (phase 0) and later (phase 4) phases. Phase 0 ... Specific laboratory requirements for Step 2 must be obtained within 2 weeks prior to Step 2 randomization.

  8. Efficacy and Safety of INCB054828 in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  9. PSMA PET For Metastatic Adenoid Cystic Carcinoma (ACC) - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  10. Colchicine and CRP in Atrial Fibrillation and AF Ablation - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...